Genmab — December 2017

[E_L]

will US tax change have an impact for JNJ?

[E_L]

By the way, JNJ also at Citi health
conference tomorrow and they will have a webcast (late)

[E_L]

on FDA lifting hold PD-(L)1 https://www.biopharmadive.com/news/fda-lifts-clinical-hold-checkpoint-inhibitors-multiple-myeloma/512404/

[Bulder]

thx EL

[JKY_VH]

Interessant tanke E L.

[Solsen]

JV du forholder dig ikke til fakta. Du tror !

[JørgenVarnæs]

Hahaha

[JørgenVarnæs]

Jeg er stadig ikke helt kommet mig over dine forecasts på receptdata

[rex_pacis]

@EI Yes, but I don't think US corporate tax will end at 20%, though it would be lovely.

[rex_pacis]

@EL sorry

[Solsen]

Det er jeg heldigvis

[E_L]

JanssenUS @JanssenUS · 32 min.
"We can't wait to share new DARZALEX (daratumumab) data in just a few days! Check out what we have in store as you get ready for #ASH17 http://po.st/8v1Bfq "

[E_L]

a bit of enthusiasm; maybe they learned from JvdW

[Bulder]

De nævner ikke Alcyone med et ord??

[Mcjean]

Alcyone er vel Darzalex i den grad Bulder eller hur?

[Mcjean]

Tror de taler generelt, lige meget hvor Darzalex bruges brager data gennem loftet, derfor siger de bare Darzalex i generelle termer.

[E_L]

they linked to the old press release from november, no worries

[Bulder]

Okey I see now, November 1

[Bulder]

Har det været nævnt at bb2121 har fået BTD af FDA og PRIME af EMA? http://ir.celgene.com/releasedetail.cfm?releaseid=1049014

[Budweis]

Janssen can’t wait - https://twitter.com/janssenus/status/938471606158024704